← Back to Clinical Trials
Recruiting NCT06163014

NCT06163014 My Symptoms: an eHealth and GP Assisted Programme for Persistent Symptoms in Primary Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06163014
Status Recruiting
Phase
Sponsor Aarhus University Hospital
Condition Persistent Physical Symptoms
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2023-12-01
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
My Symptoms eHealth programme

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2023-12-01 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.mine-symptomer.dk. The research programme is an ambitious and dedicated effort aiming at improvement of functioning and quality of life for individuals with persistent physical symptoms (PPS) and prevention of the development of chronic functional disorders and associated loss of working capacity and high use of health care. At present, access to specialized treatment of PPS is very limited and treatment capacity in general practice is restricted to brief consultations - often with poor opportunity to make a treatment plan for symptoms. As part of the research programme, the investigators have developed a web-based self-help programme for patient with PPS. This treatment programme is prescribed by the patient's general practitioner (GP). Only GPs who have participated in a short introduction course will be allowed for prescriptions. The investigators have applied a high degree of user involvement (GPs and patients) in the development process but there is a need to evaluate how the new treatment programme is in fact adopted by GPs and patients. With this study, the investigators wish to follow the national implementation using a before-after study design describing uptake and effects on GPs, patients and the health care system.

Eligibility Criteria

Inclusion Criteria: * Age 18-65 (target population for the programme) * The consultation targets symptom complaints * Listed with participating practice. Exclusion Criteria: * Symptoms are acute (not persistent) and there is no need for this intervention * Symptoms must primarily be treated by medicine or surgery * Patient severely affected by other disease * Not eligible due to language or cognitive problems

Contact & Investigator

Central Contact

Marianne Rosendal, PhD

✉ marose@rm.dk

📞 +4521476826

Frequently Asked Questions

Who can join the NCT06163014 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Persistent Physical Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06163014 currently recruiting?

Yes, NCT06163014 is actively recruiting participants. Contact the research team at marose@rm.dk for enrollment information.

Where is the NCT06163014 trial being conducted?

This trial is being conducted at Aarhus, Denmark.

Who is sponsoring the NCT06163014 clinical trial?

NCT06163014 is sponsored by Aarhus University Hospital. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology